Brentview Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.08M Buy
5,906
+188
+3% +$192K 2.8% 14
2026
Q1
$5.26M Buy
5,718
+146
+3% +$148K 2.27% 24
2025
Q4
$5.99M Buy
5,572
+27
+0.5% +$25.8K 2.71% 12
2025
Q3
$4.23M Buy
5,545
+171
+3% +$127K 1.93% 27
2025
Q2
$4.19M Buy
5,374
+1,500
+39% +$1.17M 2.12% 21
2025
Q1
$3.2M Buy
3,874
+228
+6% +$190K 1.7% 34
2024
Q4
$2.81M Buy
+3,646
New +$3.02M 1.6% 36

Other funds holding LLY

Brentview Investment Management's LLY Position: Q2 2026 in Review

Brentview Investment Management increased its Eli Lilly (LLY) stake by 3.3% in Q2 2026, buying an estimated $192K and bringing the position to 5,906 shares worth $7.08M. The position accounts for 2.8% of the portfolio, ranked #14.

Brentview Investment Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Brentview Investment Management held 5,906 shares of Eli Lilly worth $7.08M as of Q2 2026.
  • Brentview Investment Management bought 188 Eli Lilly shares in Q2 2026, an estimated $192K.
  • Eli Lilly made up 2.8% of Brentview Investment Management's portfolio in Q2 2026, its #14 holding.
  • Brentview Investment Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Brentview Investment Management's 13F filing for Q2 2026, filed 30 Jul 2026.